Evidence map›Paper›PMID 26296639›Full record

ReviewWiley interdisciplinary reviews. Nanomedicine and nanobiotechnology

Recent advances in nanotechnology-based detection and separation of circulating tumor cells.

Ja Hye Myung, Kevin A Tam, Sin-jung Park, Ashley Cha, Seungpyo Hong

Abstract readReview
In one paragraph

Review in Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Chemical science · 2020
    Article
  11. Review
  12. Review
  13. Detection of HER2ChemMedChem · 2020
    Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Multivalent Binding and Biomimetic Cell Rolling Improves the Sensitivity and Specificity of Circulating Tumor Cell Capture.Clinical cancer research : an official journal of the American Association for Cancer Research · 2018
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ja Hye MyungDepartment of Biopharmaceutical Sciences, College of Pharmacy, University of Illinois, Chicago, IL, USA.
Kevin A TamDepartment of Biopharmaceutical Sciences, College of Pharmacy, University of Illinois, Chicago, IL, USA.
Sin-jung ParkDepartment of Biopharmaceutical Sciences, College of Pharmacy, University of Illinois, Chicago, IL, USA.
Ashley ChaDepartment of Biopharmaceutical Sciences, College of Pharmacy, University of Illinois, Chicago, IL, USA.
Seungpyo HongDepartment of Biopharmaceutical Sciences, College of Pharmacy, University of Illinois, Chicago, IL, USA.

Funding

Potential therapeutic implications of targeting miR-150 in acute myeloid leukemiaR01CA182528 · NCI · UNIVERSITY OF CINCINNATI · PI CHEN, JIANJUN · 2014 to 2018
$1.7M
NCI NIH HHS R01 CA182528NCI NIH HHS R01CA182528
6 · The paper itself

Abstract

Although circulating tumor cells (CTCs) in blood have been widely investigated as a potential biomarker for diagnosis and prognosis of metastatic cancer, their inherent rarity and heterogeneity bring tremendous challenges to develop a CTC detection method with clinically significant specificity and sensitivity. With advances in nanotechnology, a series of new methods that are highly promising have emerged to enable or enhance detection and separation of CTCs from blood. In this review, we systematically categorize nanomaterials, such as gold nanoparticles, magnetic nanoparticles, quantum dots, graphenes/graphene oxides, and dendrimers and stimuli-responsive polymers, used in the newly developed CTC detection methods. This will provide a comprehensive overview of recent advances in the CTC detection achieved through application of nanotechnology as well as the challenges that these existing technologies must overcome to be directly impactful on human health.

Indexed as

Cell SeparationHumansNanostructuresNanotechnologyNeoplastic Cells, CirculatingTranslational Research, Biomedical

Identifiers

PMID26296639
PMCPMC4548820

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.